The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.

Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of technology platforms to advance therapies that span multiple diseases

Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few. Click here for a complete list of research and disease applications.

Gladstone Welcomes Todd McDevitt as the Newest Investigator at the Gladstone Institute of Cardiovascular Disease
Coming from Georgia Tech, McDevitt’s expertise in stem cell engineering will bring a unique combination of skills to compliment an existing team of world-renown scientists.
December, 2014
Better Ways to Rebuild Badly Injured Bones
Developing a new technology that will help the body repair traumatic bone injuries more effectively & at lower cost than current methods
November, 2014
Student and Faculty Researchers Converge for First-time Biomaterials Day Event
Hettiaratchi awarded 2nd place poster, Burnsed lead the organization of the event & McDevitt was 1 of 3 keynotes.
October, 2014
Study Links Biomechanics and Gene Expression in Stem Cells
McDevitt lab's work from Nature Scientific Reports featured.
August, 2014
Competitive Research Program Launches Opportunity for Mohamad Ali Najia.
For 15 years the Petit Undergraduate Research Scholars program has been like a gift that keeps on giving for talented young researchers, creating valuable opportunities for the next generation of leaders in bioengineering and bioscience.
August, 2014
Nature Materials Review: Materials as Stem Cell Regulators
Partnership with Adam Engler from UCSD and Bill Murphy from University of Wisconsin-Madison.
June, 2014
Publication Featured in Special Collection by Nature Publishing Group on Reprogramming
Nature Methods paper on uShear technology featured.
June, 2014
Research Featured in Special Issue on Natural or Biologically Inspired Building Blocks for Biomaterials Design
Compiled by Barker and Heilshorn for Acta Biomaterialia.
June, 2014
Governor Deal: Georgia Research Alliance Grant will Fuel Health Care Industry
Todd McDevitt named as Technical Lead in new nation-wide Cell Manufacturing Consortium.
May, 2014
McDevitt and the Georgia Research Alliance Partner on Nation-wide Cell Manufacturing Consortium
A scientist at the Georgia Institute of Technology is piloting a new national initiative to make the U.S. the world leader in biomanufacturing of cell therapies – projected to be a $10 billion global industry within a decade.
May, 2014
International Stem Cell Engineering Assessment

Todd was 1 of 6 panelists that toured Europe and Asia to do an international assessment of the Stem Cell Engineering field. View webcast here.

Georgia Tech Faculty Help to Define Emerging U.S Stem Cell Engineering Field through International Study. Read more.

Overview of Stem Cell Engineering


McDevitt Lab's Research Applications

Who's Visiting?